An Ebola therapy has been approved by the Food and Drug Administration for the first time. Inmazeb, an antibody cocktail made by Regeneron, received FDA approval for use against Ebola Zaire, which currently is flaring in the Democratic Republic of the Congo. (STAT)
Scientists at Oxford University have developed a rapid COVID-19 test that can detect the coronavirus in less than five minutes. Oxford researchers expressed hope that product development would begin early next year, and that an approved test device would be available six months after that. (Reuters)
Lockdowns should be a last resort for handling coronavirus outbreaks, according to the World Health Organization. The organization suggests enforcing some restrictive measures such as mask wearing and social distancing. (CNBC)
Certain blood types present a higher risk of contracting COVID-19 and becoming severely ill from the disease, according to a pair of new studies published in the journal Blood Advances. One study found that a lower percentage of people with blood type O became infected with the coronavirus, while a higher percentage of people with types A, B and AB became infected. The second study found that hospitalized COVID-19 patients with types A or AB were more likely to need mechanical ventilation. (WebMD)
MM+M’s inaugural Media Summit takes place on November 12. Register now for the virtual event. (MM+M)
